Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning

Cardiovascular Research

Volumn 26, Issue 5, 1992, Pages 456-461

  Tsuchida, Akihito ^a   Miura, Tetsuji ^a   Miki, Takayuki ^a   Shimamoto, Kazuaki ^a   Iimura, Osamu ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adenosine; Infarct size; Myocardial ischaemia; Preconditioning

Indexed keywords

8 PHENYLTHEOPHYLLINE; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR; PHENYLISOPROPYLADENOSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMAL; DISEASE MODELS, ANIMAL; HEMODYNAMICS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PHENYLISOPROPYLADENOSINE; RABBITS; RECEPTORS, PURINERGIC; THEOPHYLLINE;

EID: 85047678634     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1093/cvr/26.5.456     Document Type: Article

References (22)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986:74:1124-36.
2. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990:66:913-31.
3. Iwamoto T, Miura T, Adachi T, et al. Myocardial infarct size-limiting effect of ischemic preconditioning was not attenuated by oxygen free radical scavengers in the rabbit. Circulation 1991;83:1015-22.
4. Thornton JD, Striplin S, Lie GS, et al. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol 1990;259:H1822-5.
5. Schott R, Nao B, Strieter R. et al. Heat shock does not “precondition” canine myocardium (abstract). Circulation 1990;82(suppl III):III-464.
6. Miura T, Noto T, Adachi T, et al. Does myocardial stunning contribute to infarct limitation by preconditioning? Circulation 1991:84:2504-12
7. Murry CE, Richard VJ, Jennings RB, Reimer KA. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 1991;260:H796-804.
8. Vegh A, Szekers L, Parratt JR. Protective effects of preconditioning of the ischemic myocardium involve cyclo-oxygenase products. Cardiovasc Res 1990;24:1020-3.
9. Auchampach JA, Gross GJ. Myocardial preconditioning is mediated by activation of the ATP regulated potassium channel (abstract). FASEB J 1991;5:A1103.
10. Li Y, Kloner RA. Is ischemic “preconditioning” mediated by cardioprotective prostanoids? (abstract) Circulation 1991; 84(suppl II):II-619.
11. Thornton J, Downey JM. Blockade of ATP-sensitive potassium channels does not prevent preconditioning in rabbit heart (abstract). Circulation 1991; 84(suppl II):II-432.
12. Downey JM. The role of adenosine in preconditioning (abstract). J Mol Cell Cardiol 1991;23(suppl III):S28.
13. Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by Al adenosine receptors in rabbit heart. Circulation 1991;84:350-6.
14. Thornton JD, Liu GS, Olsson RA, Downey JAM. Intravenous Al selective adenosine agonists limit infarct size in the rabbit heart (abstract). FASEB J 1991;5:A1104.
15. Shirato C, Miura T, Ooiwa H, Toyofuku T. Wilborn WH. Downey JM. Tetrazolium artifactually indicates superoxide dismutase-induced salvage in reperfused rabbit heart. J Mol Cell Cardiol 1989;21:1187-93.
16. Griffith SG, Meghji P, Moody CJ. Burnstock G. 8-Phenyltheophylline: a potent Pl-purinoceptor antagonist. Eur J Pharmacol 1981;75:61-4.
17. Miura T, Downey JM, Hotta D, Iimura O. Effect of superoxide dismutase plus catalase on myocardial infarct size in rabbits. Can J Cardiol 1988;4:407-11.
18. Jeremy RW, Stahl L, Gillinov M, Litt M, Aversano TR, Becker LC. Preservation of coronary flow reserve in stunned myocardium. Am J Physiol 1989;256:HI303-10.
19. Marcus M. The coronary circulation in health and disease. New York: McGraw-Hill Book Co, 1983:93-112.
20. Olsson RA, Pearson JD. Cardiovascular purinoceptor. Phvsiol Rev 1990;70:761-845.
21. Schwartz ER, Mohri M, Sack S, Arras M. The role of adenosine and its Al-receptor in ischemic preconditioning (abstract). Circulation 1991;84(suppl II):II-I91.
22. Adachi T, Miura T, Noto T, et al. Does verapamil limit myocardial infarct size in a heart deficient in xanthine oxidase? Clin Exp Pharmacol Physiol 1990;17:769-79.